Becton, Dickinson and Company, commonly known as BD, is a global leader in the medical technology industry, headquartered in the United States. Founded in 1897, BD has established a strong presence in major operational regions, including North America, Europe, and Asia-Pacific. The company focuses on three primary business areas: BD Medical, BD Life Sciences, and BD Biosciences, offering innovative products and solutions that enhance patient care and improve healthcare outcomes. BD is renowned for its advanced medical devices, laboratory instruments, and diagnostic systems, which are distinguished by their commitment to quality and safety. With a rich history of innovation, BD has achieved significant milestones, including the development of the first safety-engineered needle. As a trusted partner in healthcare, BD continues to maintain a strong market position, recognised for its contributions to improving global health standards.
How does Bd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bd's score of 55 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Becton, Dickinson and Company (BD) reported total greenhouse gas emissions of approximately 7,000,000,000 kg CO2e, with emissions distributed across various scopes: 169,951,000 kg CO2e (Scope 1), 255,695,000 kg CO2e (Scope 2), and 6,633,180,000 kg CO2e (Scope 3). The company has made significant strides in reducing its emissions, achieving a 75% reduction in Scope 1 and 2 emissions relative to its 2020 goal of a 50% reduction, normalised to the Cost of Products Sold (COPS). BD has set ambitious climate commitments, aiming for a 46% reduction in Scope 1 and 2 emissions by 2030 from a 2019 baseline, and to achieve carbon neutrality across its direct operations by 2040. Furthermore, the company has committed to a long-term target of reducing absolute Scope 1 and 2 emissions by 90% by 2050, while also targeting a 97% reduction in Scope 3 emissions per unit of sold product by 2050. These targets are aligned with the Science Based Targets initiative (SBTi) and are consistent with the 1.5°C global emissions reduction pathway. BD's climate strategy reflects its commitment to sustainability and responsible corporate practices, positioning it as a leader in the healthcare equipment and supplies sector.
Access structured emissions data, company-specific emission factors, and source documents
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 96,333,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 514,801,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 158,622,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bd is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.